Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Transitional Cell × Dexamethasone × 30 days × Clear all

Sponsor

Conditions

Multiple Myeloma 57 Recurrence 8 Burkitt Lymphoma 8 Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Immunoglobulin Light-chain Amyloidosis 7 Neoplasms 6 Prostatic Neoplasms 5 Leukemia, Biphenotypic, Acute 4 Paraproteinemias 3 Neoplasm Metastasis 3 Lung Neoplasms 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Ovarian Neoplasms 2 Neoplasms, Plasma Cell 2 Lymphoma, Large B-Cell, Diffuse 2 Colorectal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Brain Neoplasms 2 Adenocarcinoma 2 beta-Thalassemia 1 Vomiting 1 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Thalassemia 1 Supratentorial Neoplasms 1 Smoldering Multiple Myeloma 1 Renal Insufficiency 1 Rectal Neoplasms 1 Radiation Pneumonitis 1

Interventions

pembrolizumab 14 enfortumab vedotin 10 Specimen Handling 8 Magnetic Resonance Spectroscopy 8 Nivolumab 7 Carboplatin 5 avelumab 4 Ipilimumab 4 Cisplatin 4 Gemcitabine 3 Docetaxel 3 sacituzumab govitecan 2 cabozantinib 2 atezolizumab 2 Paclitaxel 2 CTLA-4 Antigen 2 Biopsy 2 zimberelimab 1 zanidatamab 1 tazemetostat 1 soluble LAG-3 protein, human 1 sargramostim 1 sapanisertib 1 relatlimab 1 regorafenib 1 lenvatinib 1 erdafitinib 1 durvalumab 1 dodecyl maltoside 1 darolutamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡